Mid Florida Hematology and Oncology Centers — Orange City, Florida

Mid Florida Hematology and Oncology Centers is a clinical research site located in Orange City, Florida, United States 32763.

Crixeo Health Trust Score: 72/100 (FAIR). This profile has not yet been claimed by the site owner.

Mid Florida Hematology and Oncology Centers has participated in 5 clinical trials with 1 currently active.

Therapeutic areas: Myelodysplastic Syndrome, MDS, Refractory Anemia With Excess Blasts.

Sponsors: Traws Pharma, Inc., Aeglea Biotherapeutics, Bristol-Myers Squibb.

Sponsor Feasibility Report

Trust Score: 72/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Mid Florida Hematology and Oncology Centers?

Mid Florida Hematology and Oncology Centers has a Crixeo Trust Score of 72/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Mid Florida Hematology and Oncology Centers conducted?

Mid Florida Hematology and Oncology Centers has 5 clinical trials on record, with 1 currently active. Their work covers Myelodysplastic Syndrome, MDS, Refractory Anemia With Excess Blasts.

Is Mid Florida Hematology and Oncology Centers accredited by Crixeo Health?

Yes — Mid Florida Hematology and Oncology Centers holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Mid Florida Hematology and Oncology Centers?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.